生物技术合作交易：2019-2025

《生物技术合作伙伴关係》深入了解并分析了公司如何以及为何达成合作协议。这份经过全面修订和更新的报告提供了 2019 年至 2025 年合作协议的详细资讯。

本报告提供双方宣布的联合研究协议的付款条款。这些数据为付款条款和其他贸易条款提供了宝贵的见解。

了解潜在合作伙伴谈判交易条款的弹性可以为谈判过程提供重要的见解，让您了解谈判条款时会发生什么。许多中小企业可能会要求详细的付款条款，但付款方式和权利转让方式的细节却很重要。

本报告提供了当前协议交易和联盟资料库中记录的自 2019 年以来宣布的联盟的综合列表，包括可用的财务条款，以及公司及其合作伙伴向 SEC 提交的实际联盟协议文件的在线副本链接。

报告的第一章提供了合作交易和商业活动的指导。

第 1 章描述了本报告的介绍，第 2 章概述并分析了联盟趋势，并考虑了不同类型联盟的好处。

第 3 章概述了合作协议的结构。

第 4 章回顾了 2019 年以来的主要合作交易。交易按总金额列出。如果交易与美国证券交易委员会 (SEC) 公布了协议，则该连结可透过当前协议交易和合作伙伴关係资料库在线存取该协议。

第 5 章提供了最活跃的 25 家合作伙伴製造商的综合清单。每个交易标题都透过当前协议的交易和联盟资料库连结到完整交易记录的线上版本，并在可用时连结到实际合约文件，从而可以轻鬆按需存取每个交易记录。

第 6 章全面深入地回顾了自 2019 年以来达成或宣布的合作交易，并提供合约文件，按公司 A-Z、疗法、技术和行业进行组织。合约文件详细介绍了双方就合作交易达成的实际条款和条件。

交易目录包含自 2019 年以来宣布的所有合作研究交易的综合清单。每个清单都按公司 A-Z、治疗领域和技术类型组织成交易目录。每个交易标题都透过超连结连结到交易记录的线上版本，包括实际的合约文件（如果有）。

该报告还包含大量图表和图形，展示了 2019 年及以后的合作研究交易趋势和活动。

目录

摘要整理

第1章 简介

第2章 联盟交易趋势

• 简介
• 合作契约定义
• 2019年以后的联盟交易趋势
  • 联盟交易的各年度转变，2019年～2025年
  • 联盟交易，2019年～2025年，各开发阶段
  • 联盟交易，2019年～2025年，各业界
  • 联盟交易，2019年～2025年，各治疗领域
  • 联盟交易，2019年～2025年，各技术类型
  • 最活跃的各企业联盟交易，2019年～2025年
• 签订联盟契约的理由
• 合作契约的未来

第3章 合作契约结构概要

• 简介
• 合作协定结构

第4章 主要联盟交易

• 简介
• 以价值为排名的顶级合作交易

第5章 最活跃的联盟交易厂商主要25公司

• 简介
• 最活跃的联盟交易厂商主要25公司

第6章 -合作交易（含合约目录）

• 简介
• 2019 年至 2025 年期间签订的合作协议
• 贸易目录
• 贸易目录 - 按公司列出的业务合作伙伴清单 (AZ)
• 交易目录 - 按治疗领域划分的合作交易
• 交易目录 - 以技术类型划分的合作交易
• 关于研究公司
• 当前合作伙伴关係
• 当前合约
• Current Partnering 的最新报告标题

Collaboration Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter collaboration deals.

Fully revised and updated, the report provides details of collaboration deals from 2019 to 2025.

The report provides access to collaboration deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of collaboration deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual collaboration contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of collaboration dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in collaboration as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of collaboration deals.

Chapter 4 provides a review of the leading collaboration deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active collaboration dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of collaboration deals organized by company A-Z, therapy, technology and industry type signed and announced since 2019 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the collaboration deal.

The deal directory includes a comprehensive listing of all collaboration deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in collaboration dealmaking since 2019.

In conclusion, this report provides everything a prospective dealmaker needs to know about collaboration alliances.

Key benefits

Collaboration Deals in Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2019
• Browse collaboration deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Collaboration Deals in Biotechnology is intended to provide the reader with an in-depth understanding of the collaboration trends and structure of deals entered into by leading biopharma companies worldwide.

Collaboration Deals in Biotechnology includes:

• Trends in collaboration dealmaking in the biotechnology industry
• Overview of collaboration deal structure
• Directory of collaboration deal records covering biotechnology and biotechnology
• The leading collaboration deals by value
• Most active collaboration dealmakers
• The leading collaboration partnering resources

In Collaboration Deals in Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Collaboration Deals in Biotechnology provides comprehensive access to available records for collaboration deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What subcollaboration and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in collaboration dealmaking

• 2.1. Introduction
• 2.2. Definition of collaboration deal
• 2.3. Trends in collaboration deals since 2019
  • 2.3.1. Collaboration dealmaking by year, 2019-2025
  • 2.3.2. Collaboration dealmaking by phase of development, 2019-2025
  • 2.3.3. Collaboration dealmaking by industry sector, 2019-2025
  • 2.3.4. Collaboration dealmaking by therapy area, 2019-2025
  • 2.3.5. Collaboration dealmaking by technology type, 2019-2025
  • 2.3.6. Collaboration dealmaking by most active company, 2019-2025
• 2.4. Reasons for entering into collaboration partnering deals
• 2.5. The future of collaboration deals

Chapter 3 - Overview of collaboration deal structure

• 3.1. Introduction
• 3.2. Collaboration agreement structure

Chapter 4 - Leading collaboration deals

• 4.1. Introduction
• 4.2. Top collaboration deals by value

Chapter 5 - Top 25 most active collaboration dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active collaboration dealmakers

Chapter 6 - Collaboration deals including contracts directory

• 6.1. Introduction
• 6.2. Collaboration deals with contracts 2019-2025
• Deal directory
• Deal directory - collaboration dealmaking by companies A-Z
• Deal directory - collaboration dealmaking by therapy area
• Deal directory - collaboration dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of collaboration deal
• Figure 2: Trends in collaboration deal announcements, 2019-2025
• Figure 3: Collaboration deals signed at each phase of development, 2019-2025
• Figure 4: Collaboration deals by industry sector, 2019-2025
• Figure 5: Collaboration deals by therapy area, 2019-2025
• Figure 6: Collaboration deals by technology type, 2019-2025
• Figure 7: Top 25 most active collaboration dealmakers, 2019-2025
• Figure 8: Top collaboration deals by value, 2019-2025
• Figure 9: Most active collaboration dealmakers, 2019-2025